Research Paper Volume 11, Issue 18 pp 7442—7456
Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer
Figure 11. FOXA1 as a prognosis marker in breast cancer. (A) Expression of FOXA1 in tumor (32 cases) and adjacent normal mammary epithelium (19 cases). (B) Kaplan-Meier curves based on FOXA1 expression were drawn for overall survival in 32 patients.